Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2005-10-04
2005-10-04
Raymond, Richard L. (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C514S408000, C514S412000, C514S415000, C514S424000, C548S469000, C548S485000, C548S511000, C548S452000
Reexamination Certificate
active
06951848
ABSTRACT:
Disclosed are novel compounds having the formulaor a physiologically acceptable salt, amide, ester or prodrug thereof. The compounds can be used to modulate (antagonize, agonize) chemokine receptor function. Also disclosed is a method for treating a patient having an inflammatory disease and/or viral infection comprising administering an effective amount of a compound of Formula I. In particular embodiments, the invention is a method for treating a patient infected with HIV.
REFERENCES:
patent: 4133814 (1979-01-01), Jones et al.
patent: 4810801 (1989-03-01), Mertens et al.
patent: 5414088 (1995-05-01), Von Der Saal et al.
patent: 5556874 (1996-09-01), Dobrusin et al.
patent: 5955492 (1999-09-01), Thompson et al.
patent: 6410540 (2002-06-01), Goehring et al.
patent: 2002/0068752 (2002-06-01), Augelli-Szafran et al.
patent: 3445669 (1986-06-01), None
patent: 3932953 (1991-04-01), None
patent: 39335514 (1991-05-01), None
patent: 1 191 027 (2002-03-01), None
patent: 52053851 (1977-04-01), None
patent: WO 97/35572 (1997-10-01), None
patent: 9819997 (1998-05-01), None
patent: WO 99/41239 (1999-08-01), None
patent: WO 00/12074 (2000-03-01), None
patent: WO 00/42045 (2000-07-01), None
DeGraw et al,J. Medicinal Chem.,7/2,213-15(1964), also cited as Chemical Abstract DN 60:68112.
Chemical Abstract DN 115:92265, also cited as DE 3935514.
Chemical Abstract DN 115:92262, also cited as DE 3932953.
Chemical Abstract DN 111:115180,also cited as 4810801.
Chemical Abstract DN 52:72273, also cited as Zhurnal Obshschei Khimii, 28,78-87(1958).
Chemical Abstract DN 105:152998, also cited as J. Med. Chem., 29/9,1637-43(*1986).
Chemical Abstract DN: 90:151974, also cited as JP 52053851.
Debnath et al, J. Med. Chem., 42,3202-9(1999).
Verani et al, PuibMed Abstract 12462390, also cited as Curr. Mol. Med., 2/8, 691-702(2002).
Agrawal et al(Expert Opinion Ther. Targetrs 5/3, 303-326(2001).
Tagat et al,Bioorgic & Med. Chem. Letters, 11,2143-46(2001).
Granata et al, PubMed. 12876405, also cited as Int. Arch Allergy Immunol., 13/3,153-63(2003).
Scott et al, PubMed Abstract 12783578, also cited as Expert Opin. Ther. Targets,7/3,427-40(2003).
Cecil Textbook of Medicine, Vool. 1, 20thEdn.,pp. 1004-1010(1996).
F.M.Uckun t al,Current Cancer Drug Targets,1,59-71(2001).
Mikerova, N.I. et al., “Synthesis and Antiviral Activity of Derivatives of 2-Methyl-3-Ethoxycarbonyl-5-(5-Nitropyrimid-4-YL)Oxyindole,”Pharm. Chem. J., 25(6) :391-393 (1991).
Purohit, M.G. et al., “Synthesis and Antiserotonin Activity of Ethyl 5-0- (4-Methylpiperazin-1-ylacetyl) -2-Methylindole-3-Carboxylates and 3-(4-Methyl-1-Piperazinyl-glyoxylyl)indoles,”Indian Journal of Chemistry, 34B(9) :796-801 (1995).
Grinev, A.N. et al.,Chemical Abstracts, 74(5), 22645u (1971).
Wrotek, J. et al.,Chemical Abstracts, 75(25), 151627j (1971).
Gadaginamath, G.S. et al.,Chemical Abstracts, 131(3), 31897a (1999).
Fadeeva, N.I. et al.,Chemical Abstracts, 115(15), 158914d (1991).
Gadaginamath, G.S. et al.,Chemical Abstracts, 124(11), 146011e (1996).
Mezentseva, M.V. et al.,Chemical Abstracts, 115(13), 135866a (1991).
Zemskii, B.P. et al.,Chemical Abstracts, 91(7), 56952h, (1979).
Shvedov, V.I. et al.,Chemical Abstracts, 94(11), 76565z (1981).
Panisheva, E.K. et al.,Chemical Abstracts, 115(5), 49345y (1991).
Zemskii, B.P. et al., “Synthesis and Neurotropic Activity of Heterocyclic Derivatives of 1-Piperazinylalkylindoles,”Pharm. Chem. J., 13(4) :378-381 (1979).
Carson Kenneth G.
Flynn Daniel L.
Harriman Geraldine C. B.
Kolz Christine N.
Pham Ly
Millennium Pharmaceuticals Inc.
Patel Sudhaker B.
Raymond Richard L.
LandOfFree
Functionalized heterocycles as modulators of chemokine... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Functionalized heterocycles as modulators of chemokine..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Functionalized heterocycles as modulators of chemokine... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3439860